Related Experiment Video
Updated: Jun 29, 2025

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
Ammoniagenic Action of Valproate without Signs of Hepatic Dysfunction in Rats: Possible Causes and Supporting
Gubidat Alilova1, Lyudmila Tikhonova1, Carmina Montoliu2,3
1Laboratory of Cell Engineering, Institute of Theoretical and Experimental Biophysics of Russian Academy of Sciences, 142290 Pushchino, Russia.
Valproic acid (VPA) can increase ammonia in specific rat brain regions, even without liver issues. This study reveals VPA
Area of Science:
- Neuroscience
- Biochemistry
- Pharmacology
Background:
- Valproic acid (VPA) is a common antiepileptic drug.
- Neurologic adverse effects of VPA can occur without liver failure.
- Brain energy metabolism and ammonia production are interconnected.
Purpose of the Study:
- Investigate regional ammoniagenic effects of VPA in rat brains.
- Determine VPA's impact on enzymes involved in ammonia production and neutralization.
- Explore VPA's role in VPA-induced encephalopathy mechanisms.
Main Methods:
- Rats received single intraperitoneal injections of VPA (50-500 mg/kg).
- Plasma and brain regions (neocortex, cerebellum, hippocampus) were analyzed.
- Enzyme activities (glutaminase, GDH, AMPD, ADA, GS) and ammonia levels were measured.
Main Results:
- VPA did not significantly alter plasma ammonia, urea, ALT, or AST.
- Dose-independent ammonia accumulation occurred in cerebellar cytosol, correlated with ADA activity.
- Mitochondrial ammonia increased dose-independently in all brain regions, linked to GDH and ALT activity.
Conclusions:
- VPA exhibits region-specific ammoniagenic effects in the rat brain.
- These effects can manifest independently of systemic hyperammonemia.
- Further research is needed on brain region-specific responses and energy metabolism.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
09:44Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Related Concept Videos
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
Physical Properties of Amines